Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Russia

Leveraging Digital Technologies to Create Valuable KOL Engagements & Empower Patients

Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to...

Impetus Digital

Roles of Neuroscience & AI in Solving Complex Healthcare Challenges

Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks, discusses all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital...

Impetus Digital

- PMLiVE

Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses

New developments for COVID-19 treatments and vaccines

- PMLiVE

AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death

Reports indicate that the death occurred in the placebo group

- PMLiVE

Independent consultant will review Lilly’s COVID-19 plant issues

COVID-19 antibody trial was paused last week due to safety issue

AstraZeneca AZ

AZ’s US-based COVID-19 vaccine trial could restart this week

Sources briefed on the matter disclosed possible timeline to Reuters

How will COVID-19 affect uptake of vaccinations against other diseases?

Will COVID-19 help or hinder the quest to increase uptake of other vaccinations?

- PMLiVE

Moderna’s chief exec expects to have COVID-19 vaccine data in November

If data is promising, company could seek emergency use authorisation in the US in December

- PMLiVE

UK government invests in human challenge trials for COVID-19

The trials could begin in 2021 if approved by regulators

- PMLiVE

WHO trial casts doubt on remdesivir’s efficacy

Drug's developer Gilead hits back at the findings

- PMLiVE

Pfizer CEO pushes back COVID-19 vaccine submission to November

Company previously said it would seek approval by October

Sanofi reception

Sanofi and Translate Bio eye launch of phase 1/2 COVID-19 vaccine study

Preclinical data for mRNA-based vaccine supports clinical development

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links